Skip to content

NDMM ~ Tweetorial #1: Efficacy of Quad Therapies
*Pre-assessment*

Before you view this activity, please take this pre-assessment. Taking this pre-assessment does not immediately qualify learners to earn credit. 

Certificates of credit will only be sent to learners who also receive a passing score on the post-test (separate from this survey), and fill out the evaluation form and application for credit.
1.What are your credentials?(Required.)
2.What is your community of practice?
3.CEPHEUS compared induction/consolidation w VRd ± daratumumab (D) followed by maintenance in transplant-ineligible (TIE) NDMM.

DVRd arm demonstrated which of the following outcomes?(Required.)
4.Unfortunately, pts w high-risk (HR) NDMM have 👎prognosis & shorter survival rates vs standard-risk.

Based on results of GMMG-CONCEPT presented at ASCO2025, which treatment strategy should be used for pts w/HRNDMM?(Required.)
5.Please let us know who you are so we can connect your responses to your post-test & application to claim CME credit (completed after participating in the activity). 

Completing the fields below does not immediately qualify you for a CME certificate. Only after completing the post-survey & evaluation form will a certificate be issued.

*Please note that we will not forward or sell your contact information.
6.View the activity (link will be live only after program launches)
🔗 Take the post-survey
Privacy & Cookie Notice